Tag Archives: after

NICE blames BioMarin for Brineura rejection after price talks break down

BioMarin and England’s cost-effectiveness gatekeeper have been negotiating for a year, but that hasn’t helped the rare-disease specialist secure reimbursement for its Batten disease drug Brineura. Friday, the National Institute for Health and Care Excellence (NICE) published draft guidance sticking with its earlier decision not to endorse Brineura in children with the disease, an inherited… Read More »

Backlash after study refutes idea that breakfast is the most important meal of the day

Farewell, pancakes? Farewell, breakfast sausage? A new review that suggests breakfast skippers eat fewer calories over the day and weigh slightly less than breakfast eaters is reigniting debate over the quaint notion that breakfast is “the most important meal of the day.” While some experts say the research is further evidence skipping breakfast might be… Read More »